tradmap

ILMN Illumina, Inc.

$221.69 +3.90%

Updated

Healthcare · Laboratory Analytical Instruments

Illumina, Inc. (ILMN) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $33.5 billion. Shares last traded at $221.69, 4.3% below their 52-week high. Over the past year the stock is up 130.8%. ILMN trades at a price-to-earnings ratio of 40.58, below the Laboratory Analytical Instruments median of 43.69. Net profit margin is 18.4%, above the peer median of -1.7%. Revenue declined 0.7% year over year.

Market Cap
$33.5B
Shares Out
151.0M
EPS (TTM)
$8.69
P/E Ratio
25.51
P/S Ratio
7.45
P/B Ratio
11.80
Dividend / Share
Dividend Yield
52-Week High
$231.76
52-Week Low
$88.00
Volume
158,955
Avg Vol (3m)
126,246.889

Performance

1W
-2.63%
1M
+10.91%
3M
+31.96%
6M
+72.90%
YTD
+64.97%
1Y
+130.76%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
61.30
SMA (50)
$197.53
SMA (200)
$151.41
Price vs SMA50
+12.23%
Price vs SMA200
+46.42%
ATR (14)
$8.80

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$4.5B
Net Income
$825M
Gross Margin
66.4%
Operating Margin
19.6%
Net Margin
18.4%
Return on Equity
29.1%
Return on Assets
12.4%
Current Ratio
1.80
Debt / Equity
0.24
Revenue Growth (YoY)
-0.7%

Latest reported annual period ending 2026-06-28 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $2.22 2026-07-31
Q1 2026 $0.87 2026-05-04
FY 2025 $5.45 2026-02-12
Q3 2025 $3.29 2025-10-31
Q2 2026 $2.31 2026-07-31
Q1 2026 $0.82 2026-05-04

Full earnings history →

Laboratory Analytical Instruments peers

ILMN vs 14 industry peers (Laboratory Analytical Instruments), by market cap. Updated

P/E vs peers
40.58 / 43.69 med
-7% discount
P/S vs peers
7.45 / 5.01 med
+49% premium
Net margin vs peers
18.4% / -1.7% med
above median
1–14 of 14
AAgilent Technologies$42.3B29.355.7319.5%-0.93%
WATWaters Corporation$40.6B63.248.7513.8%+0.36%
ILMNIllumina, Inc.$33.5B40.587.4518.4%+3.90%
MTDMettler Toledo$27.2B30.016.5821.9%-0.77%
RVTYRevvity$14.6B61.375.018.2%-0.24%
BIOBio-Rad Laboratories, Inc.$10.4B46.814.028.6%-0.19%
AVTRAvantor, Inc.$10.4B-18.811.58-8.4%+3.65%
BRKRBruker Corp$9.1B-127.122.59-2.0%+0.61%
TXG10x Genomics, Inc.$8.2B-108.5013.21-12.2%+2.45%
ALMRAlamar Biosciences, Inc.$2.1B+0.51%
CTKBCytek Biosciences, Inc.$611M-9.182.96-32.2%+0.21%
MASS908 Devices Inc.$414M-11.956.81-57.0%-3.05%
PACBPacific Biosciences Of California, Inc.$403M-3.06-1.52%
EYPTEyepoint, Inc.$394M-1.28-4.39%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.